Author:
Kubitza Dagmar,Becka Michael,Zuehlsdorf Michael,Mueck Wolfgang
Subject
Pharmacology (medical),Pharmacology
Reference9 articles.
1. New anticoagulants: beyond heparin, low-molecular-weight heparin and warfarin;Bates;Br J Pharmacol,2005
2. In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939-an oral, direct Factor Xa inhibitor;Perzborn;J Thromb Haemost,2005
3. BAY 59-7939: an oral, direct Factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement: a phase II dose-ranging study;Turpie;J Thromb Haemost,2005
4. Oral, direct Factor Xa inhibition with BAY 59-7939 for the prevention of venous thromboembolism after elective hip replacement;Eriksson;J Thromb Haemost,2006
5. Safety, pharmacodynamics and pharmacokinetics of BAY 59-7939-an oral, direct Factor Xa inhibitor-after multiple dosing in healthy male subjects;Kubitza;Eur J Clin Pharmacol,2005
Cited by
229 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献